NR1I3 and metabolic dysfunction-associated steatotic liver disease: In conclusion, this study provides valuable insights into the dimorphic pathogenesis of NAFLD, unveiling the protective role of the nuclear receptor CAR in mitigating HFD-induced metabolic disruptions, particularly in females.